Giuseppe Colucci,Sara Uceda Renteria,Giovanna Lunghi et al.
Giuseppe Colucci et al.
Background: Migrants represent a key target population for viral hepatitis micro-elimination programs and are important targets for specific prevention, screening and treatment programs. ...
Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma [0.03%]
卡瑞利珠单抗联合TACE治疗巨块型肝癌患者的疗效分析
Sujing Zhang,Yingchun Zhao,Li He et al.
Sujing Zhang et al.
Objective: To investigate the efficacy of camrelizumab plus transarterial chemoembolization (TACE) on massive hepatocellular carcinoma (HCC) patients. Met...
Randomized Controlled Trial
Clinics and research in hepatology and gastroenterology. 2022 Apr;46(4):101851. DOI:10.1016/j.clinre.2021.101851 2022
Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners [0.03%]
糖尿病专家与全科医师对慢性肝病认知的比较
Clémence M Canivet,Sarra Smati,Adrien Lannes et al.
Clémence M Canivet et al.
Backgrounds and aims: Because of the high prevalence of chronic liver disease (CLD), it is crucial that general practitioners (GPs, in contact with the general population) and diabetologists (in contact with the most at-r...
Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study [0.03%]
非酒精性脂肪肝病患者中 NLPR3 炎症小体上调激活被花青素抑制：一项病例对照研究和干预研究
Xuan Zhu,Xiaozhuan Lin,Peiwen Zhang et al.
Xuan Zhu et al.
Objectives: Despite the recent attention focused on the roles of the NLRP3 inflammasome in the pathogenesis of metabolic and inflammatory diseases, little is known about the activation status of NLRP3 inflammasome in pati...
Randomized Controlled Trial
Clinics and research in hepatology and gastroenterology. 2022 Apr;46(4):101843. DOI:10.1016/j.clinre.2021.101843 2022
Chronic pancreatitis with type V Bartter syndrome: An unusual presentation [0.03%]
慢性胰腺炎伴巴特尔综合征型V：一种不常见的表现形式
Prajna Anirvan,Pankaj Bharali,Mrinal Gogoi et al.
Prajna Anirvan et al.
Rituximab and plasmapheresis for severe post-transplant auto-immune hepatitis [0.03%]
利妥昔单抗和血浆置换治疗重症移植后自身免疫性肝炎
Jérôme Dumortier,Yasmina Chouik,Olivier Hequet et al.
Jérôme Dumortier et al.
Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis [0.03%]
他汀类药物治疗非酒精性脂肪肝病或非酒精性脂肪性肝炎的临床效益
Vasilios G Athyros,Niki Katsiki,Dimitri P Mikhailidis
Vasilios G Athyros
NLR contributed to the diagnosis and detection of nonalcoholic fatty liver disease: A meta - analysis [0.03%]
NLR在非酒精性脂肪肝病诊断和检测中的作用：一项荟萃分析研究
Jiake Tang,Chen Chen,Mengyun Zhou et al.
Jiake Tang et al.
The utility of CT Colonography in colonic diaphragm disease: Case report [0.03%]
结肠膈疾病CT结肠造影检查的效用：病例报告
Natallia Khenkina,Salvatore Di Pietro,Sofia Scolari et al.
Natallia Khenkina et al.
A novel XIAP mutation in an adult Chinese patient with refractory Crohn's disease [0.03%]
成人顽固性克罗恩病患者XIAP新突变病例报告
Chengcheng He,Hejun Li,Peirong Zhou et al.
Chengcheng He et al.